🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Status
Recruiting
Location
Research Site
Start Date
2023-07-28
Trial ID
NCT06068049
RATIONALE: Pemetrexed disodium may stop the growth of tumor cells by blocki...
Status
Terminated
Location
University of Michigan Comprehensive Cancer Center
Start Date
2006-05
Trial ID
NCT00438204
Treatments Being Tested
This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-06-30
Trial ID
NCT04971187
Treatments Being Tested
This is a single-center, open-label, phase I clinical trial aimed to evalua...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-08-01
Trial ID
NCT05507606
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This is a prospective, multi-center, single arm study assessing the efficac...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2021-01-21
Trial ID
NCT04982549
Treatments Being Tested
To determine the toxicities, maximum tolerated dose (MTD) and recommended p...
Status
Completed
Location
Indiana University Cancer Center
Start Date
2006-10
Trial ID
NCT00408226
Treatments Being Tested
The purposes of this study are to determine: 1. The safety of pemetrexed p...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2003-02
Trial ID
NCT00061464
Treatments Being Tested
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
The purpose of this study is to evaluate the efficacy and safety of divaras...
Status
Recruiting
Location
Alaska Oncology and Hematology
Start Date
2025-10-24
Trial ID
NCT06793215
Treatments Being Tested